Drug Patent Expirations in March 2015

Drug Patent Expirations for March 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
SUSTIVA Bristol Myers Squibb efavirenz 5,663,169*PED Mar 2, 2015
ATRIPLA Gilead efavirenz; emtricitabine; tenofovir disoproxil fumarate 5,663,169*PED Mar 2, 2015
DEPOCYT Pacira Pharms Inc cytarabine 5,723,147 Mar 3, 2015
AGENERASE Glaxosmithkline amprenavir 5,723,490 Mar 3, 2015
DEPODUR Pacira Pharms Inc morphine sulfate 5,723,147 Mar 3, 2015
KYNAMRO Genzyme Corp mipomersen sodium 6,222,025 Mar 6, 2015
ENABLEX Warner Chilcott Llc darifenacin hydrobromide 5,096,890 Mar 13, 2015
ADENOSCAN Astellas adenosine 5,731,296 Mar 24, 2015
IPRIVASK Marathon Pharms Llc desirudin recombinant 5,733,874 Mar 31, 2015
MIACALCIN Sebela Ireland Ltd calcitonin salmon 5,759,565 Mar 31, 2015
ONEXTON Dow Pharm benzoyl peroxide; clindamycin phosphate 5,733,886 Mar 31, 2015
MIACALCIN Sebela Ireland Ltd calcitonin salmon 5,733,569 Mar 31, 2015
ACANYA Dow Pharm benzoyl peroxide; clindamycin phosphate 5,733,886 Mar 31, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2015 Biotechblog

Comments are closed.

%d bloggers like this: